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ABSTR ACT: Small colony variant (SCV) bacteria arise spontaneously within apparently homogeneous microbial populations, largely in response to 
environmental stresses, such as antimicrobial treatment. hey display unique phenotypic characteristics conferred in part by heritable genetic changes. 
Characteristically slow growing, SCVs comprise a minor proportion of the population from which they arise but persist by virtue of their inherent resilience 
and host adaptability. Consequently, SCVs are problematic in chronic infection, where antimicrobial treatment is administered during the acute phase of 
infection but fails to eradicate SCVs, which remain within the host causing recurrent or chronic infection. his review discusses some of the phenotypic and 
genotypic changes that enable SCVs to successfully proliferate within the host environment as potential pathogens and strategies that could ameliorate the 
resolution of infection where SCVs are present.
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Discovery of Small Colony Variants (SCVs)
Pure bacterial cultures are not genetically homogeneous, 
and their behavior is determined by genomic characteris-
tics, such as a high degree of plasticity. Slow-growing sub-
populations of bacteria in pure culture have been described 
from as early as 1913; reported to emerge in response to 
diverse environmental pressures, they were termed SCVs 
because they formed pin-prick-sized colonies when cul-
tured on solid media.1,2 Initially, SCVs were thought of as 
morphological variants with a secondary role in infectious 
disease because of their markedly diminished pathogenic-
ity and impaired production of virulence factors.2 Further-
more, it was believed that the G forms, as they were referred 
to, may even constitute an ordinary part of the microbial 
life cycle.3,4 It was not for many decades following their 
initial phenotypic characterization that the pathogenic 
potential of SCVs was realized and their presence within a 
microbial community was regarded as more than a labora-
tory curiousity.5,6
Early studies clariied the link between environmen-
tal stress and the phenotypic changes that became associ-
ated with SCVs, including atypical colony morphology, 
slow growth rate, lack of pigmentation, reduced hemolytic 
activity, reduced coagulase activity, reduced carbohydrate 
utilization, low virulence potential, and elevated antibiotic 
resistance (Fig. 1).7–9 Indeed, the growth rate of SCVs has 
been estimated to be approximately nine times slower than 
that of the progenitor organisms.10 As such, SCVs are now 
better deined as a microbial subpopulation constituting a 
naturally occurring, slow-growing but diverse bacterial 
morphotype.7,11 Clinically, this is problematic; the pres-
ence of SCVs during infection is correlated with recurrent 
or chronic infectious disease. A combination of extended 
incubation time in addition to altered phenotypic and bio-
chemical traits often means that SCVs in patient samples 
are overlooked by clinical microbiologists utilizing conven-
tional diagnostic tests. his results in the cessation of anti-
microbial treatment before SCVs are efectively cleared from 
an infection; therefore, they persist causing recurrent and 
chronic infection.7,12
Various environmental stimuli appear to result in phe-
notypically distinct varieties of SCV.7,13 Some undergo per-
manent genetic changes, whereas a subpopulation reverts to 
a wild-type (WT) phenotype or to a diferent phenotype 
that is distinct from both the progenitor and the SCV upon 
repeated subculture (revertant phenotype) (Fig. 1).14 Pheno-
typic reversion, where genetic mutations have not occurred, 
happens rapidly and circumvents any permanent itness 
costs.14 he tendency to permanent genetic alteration as com-
pared to phenotypic reversion seems to depend largely on 
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the nature of the original environmental pressure.7 here is 
not always commonality between phenotypic and genotypic 
changes within diferent SCV populations, but there are a 
number of prevalent auxotrophies, characterized initially 
in Staphylococcus spp., including hemin, thiamine, menadi-
one, thymidine, or unsaturated fatty acids.7,14–17 Conversely, 
some SCVs do not demonstrate these auxotrophies,18–21 for 
example, those of Staphylococcus aureus, selected by Triclo-
sanTM treatment, which revert neither upon supplementa-
tion with growth factors nor by repeated subculture.22,23 
he reasons why SCVs are phenotypically diverse remain 
unclear beyond an unproven link to certain environmental 
contraints.7,24,25
Unique Phenotypic Traits Associated with SCVs
In addition to the auxotrophies described above, there are a 
number of other phenotypic characteristics typically associ-
ated with SCVs that likely contribute to their ability to persist 
under adverse growth conditions. One such conventional SCV 
attribute is diminished electron transport, observed in various 
species of Staphylococcus, Enterococcus, and Pseudomonas. his 
phenotype arises as a consequence of mutations impairing the 
function of menadione, hemin, and thiamine, all of which are 
required for the biosynthesis of components of the electron 
transport chain (Table 1).7,14–16,26,27 Ordinarily, menadione is 
isoprenylated to form menaquinone, the acceptor of electrons 
from nicotinamide adenine dinucleotide (NADH)/lavin 
adenine dinucleotide (FADH2) in the electron transport 
chain, which does not occur in some SCVs.10,28,29 Subsequent 
reduced electron transport results in a decreased electrochem-
ical gradient and therefore reduced synthesis of adenosine 
triphosphate (ATP). Large amounts of ATP are required for 
cell wall biosynthesis, and electron transport is directly linked 
to the biosynthesis of carotenoid pigments, rendering many 
SCVs of pigmented species colorless.
he unique cell wall structure of SCVs is believed to con-
fer some degree of protection from stress and is allied with 
aberrant electron transport. Abnormal cell division has been 
described for SCVs of S. aureus, causing inappropriate cell 
wall biosynthesis and growth of unusually large cells.21,30–32 
SCVs of S. aureus remain to be some of the best character-
ized, and when examined by electron microscopy are revealed 
to be a heterogeneous population of difering size, including 
“empty” cells and substantial amounts of debris.29,30,33 More-
over, while WT S. aureus are spherical, with thin cell walls 
and a relatively uniform cytoplasm,34,35 their SCV counter-
parts tend to exhibit much thicker cell walls with irregular 
cytoplasm of dense granular appearance at the periphery and 
ine granular materials at the center.34 Additionally, SCVs 
with incomplete, branched, or multiple cross walls without 
regular cell separation are often also observed.7,29,30 Ghost or 
empty cells (as mentioned above and observed also for Entero-
coccus spp.) devoid of cytoplasmic content and chromosomal 
or plasmid DNA and with defective cell walls have also been 
documented; these are categorized as SCVs despite not being 
viable microorganisms.30–35
Characteristically, in addition to the aforementioned 
phenotypic changes, the small regulatory RNA molecule, 
RNAIII, is usually absent from SCVs and has been partic-
ularly well deined for SCVs of S. aureus.13,36,37 RNAIII is 
known to regulate virulence factors, including exoproteins, 
and cell wall-associated proteins, including adhesins, as well 
as act as the efector of agr-mediated quorum sensing. RNAIII 
positively regulates the production of toxins and proteases but 
negatively regulates adhesins, meaning that SCVs tend to be 
less toxigenic and more prone to adhesion to biotic or abiotic 
surfaces with enhanced intracellular persistence.38,39 Virulence 
during infection is reliant on initial colonization of the host; 
host–pathogen interactions prevail via bridging mechanisms 
involving bacterial adhesins and corresponding host proteins.40 
SCVs adhere to host cells in much the same way as WT micro-
organisms; the major diference is that SCVs express many 
more surface adhesins, thus favoring interaction with the host.
Once attached to the host cell, SCVs, like their WT 
counterparts, induce host-cell changes by actin rearrange-
ment, which mediates internalization, efectively hijacking 
non-phagocytic cells (including endothelial cells, ibroblasts, 
osteoblasts, and keratinocytes).41,42 Pathogens that are not 
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Figure 1. WT organisms undergo a shift to the SCV phenotype under the conditions of stress, where they exhibit a slower growth rate but increased 
antibiotic resistance. They can revert to a WT-like (indicated by a dashed line to denote that WT-like organisms are not identical to the original WT 
progenitor) or alternative revertant (R) phenotype when the environmental stress is removed, regaining a faster growth rate but becoming more 
susceptible to antibiotic treatment.
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Table 1. Characteristics associated with SCVs.
GENE PROTEIN FUNCTION VARIATION EXAMPLE ORGANISM(S) SELECTED 
REFERENCES
Altered interaction with the host
clfA Clumping Factor A Fibrinogen binding Increased expression in 
hemB background
Staphylococcus spp.
57
fnb Fibronectin Binding  
Protein
Fibronectin binding Increased expression in 
hemB background
57
spa Protein A Surface protein, inhibits 
phagocytosis
Transcription reduced in 
SCV: avoidance of host 
immunity
57
Altered biosynthesis or enzymatic pathways
hemL Glutamate 1-semi- 
aldehyde aminotransferase
Porphyrin biosynthesis Gene interruption causing 
persistent infection
Staphylococcus spp.
Pseudomonas aeruginosa 
Escherichia coli 
Salmonella enterica 
sv. Typhimurium 
Enterococcus spp.
52
hemB Porphobilinogen synthase Porphyrin biosynthesis Gene interruption causing 
persistent infection
52
menD 2-succinyl-6-hydroxy-2,4- 
cyclohexadine-1-carboxylate 
synthase
Cytochrome biosynthesis Gene interruption causing 
persistent infection
Staphylococcus spp. 
Pseudomonas aeruginosa 
Enterococcus spp.
7
ctaB Haem-O-monooxygenase Cytochrome biosynthesis Gene interruption causing 
persistent infection
Staphylococcus aureus 7, 39
citB Aconitase Catalyses isomerization  
of citrate to isocitrate in the 
tricarboxylic acid cycle
Down-regulated in hemB 
background
Staphylococcus spp. 13
aroD 5-dehydroquinate hydrolyase Menadione biosynthesis Defective in SCV: 
increased persistence
Staphylococcus spp. Salmo-
nella enterica sv. Typhimurium
26
ldh Lactate dehydrogenase Converts pyruvate to  
lactate in hypoxic/anoxic  
conditions
Defective in SCV: 
increased persistence
Staphylococcus spp. 26
thyA Thymidylate synthase Catalyses the conversion 
of deoxyuridine monophos-
phate (dUMP) to deoxythy-
mydine monophosphate 
(dTMP)
Varied mutations resulting  
in thymidine auxotrophy
Stenotrophomonas maltophilia 
Staphylococcus aureus 
Pseudomonas aeruginosa 
Enterococcus spp.
13, 14
Transcriptional regulation
agr Accessory gene regulator Global virulence regulator
quorum sensing
Impaired expression in  
SCV: chronicity
Staphylococcus aureus 38, 39
sarA Accessory gene regulator Global virulence regulator
ELR¿OPIRUPDWLRQ
Impaired expression in  
SCV: chronicity
Staphylococcus aureus 60, 62
sigB Alternative stress regulator Alternative stress 
regulatorintracellular 
persistence
Down-regulated or  
silenced in SCV: increased 
intracellular persistence 
and resistance to hydrogen 
peroxide stress
Bacillus cereus Staphylococ-
cus aureus
58, 59, 61, 63
Miscellaneous function
mutL Member of MutHLS complex Methyl-directed mismatch 
repair (MMR) system
Gene truncated due to  
frameshift mutations in  
thymidine-dependent SCV  
isolates: hypermutability
Pseudomonas aeruginosa 65
nupC Nucleoside permease +LJKDI¿QLW\QXFOHRVLGH
transporter
Gene mutations in  
thymidine-dependent  
SCVs
Stenotrophomonas maltophilia 
Staphylococcus aureus
7
hla α-hemolysin Initiates eukaryotic cell  
apoptosis and necrosis
Expression impaired in 
SCV: attenuated virulence 
and enhanced intracellular 
persistence
Staphylococcus aureus 7
 
categorized as SCVs utilize the same mechanism of inter-
nalization, but crucially, SCVs are far more eicient at this 
process than their progenitors.43 Fundamentally, this intra-
cellular protection afords additional defense against immune 
clearance or antimicrobial treatment. Owing to their reduced 
toxicity, the uptake of SCVs in this manner occurs in vitro 
without damage to host cells.44 Once inside the host cell, 
intracellular survival is critical to retain protection.40 SCVs 
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characteristically proliferate intracellularly, more successfully 
than their progenitors, which is a trait that directly contrib-
utes to antibiotic treatment failure and poor prognosis in 
patients.45–47 A marked increase in the expression of member 
genes of the arginine deaminase pathways in SCVs of S. aureus 
results in the reduced function of vital host enzymes involved 
in the immune response and is believed to be key to successful 
intracellular persistence.36
In addition, SCVs evade the immune response and persist 
intracellularly by escaping from intracellular phagosomes,43,48 
thus avoiding the hydrolytic activity of lysosomes.48 It has 
been proposed that unlike other intracellular pathogens, once 
in the cytoplasm, SCVs may no longer disrupt normal actin 
polymerization of the cells in which they reside, meaning that 
they do not elicit normal intracellular cytokine and chemo-
kine defense mechanisms.40 herefore, the ability of SCVs to 
dampen the proinlammatory response means that the attenu-
ated virulence associated with the SCV phenotype is in fact 
favorable for their survival and prolonged persistence within 
the host.46 he recovery of SCVs from the cases of asymp-
tomatic infection supports this theory of persistence through 
diminished host damage.48,49
Unique Genotypic Features Associated with SCVs
Several genetic mutations can result in the electron transport-
defective SCV phenotype described above, including the 
mutations in menD, hemB, and ctaA.38,44,50,51 MenD encodes 
for 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate 
synthase, which catalyses the conversion of isochorismate 
2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-car-
boxylate. HemB encodes for porphobilinogen synthase, which 
is essential for subsequent porphyrin metabolism.36,44,52–54 
CtaA encodes haem-O-monooxygenase that converts haem-
O to haem-A, which is an essential cofactor for enzymes 
involved in electron transport,53 and its deiciency inhibits 
cytochrome biosynthesis.7 Mutations in menD and hemB block 
the biosynthesis of menadione, which is used in menaquinone 
biosynthesis. Mutations in menD, hemB, or ctaA can also lead 
to defective cytochrome biosynthesis.7 Both menD and hemB 
mutations also impair the biosynthesis of cytochromes.36,44,52,53
During infection, organisms are exposed to high levels of 
haem that may be toxic because of the accumulation of super-
oxides. By virtue of the mutations described above, haem stress 
for SCVs is signiicantly alleviated, suggesting that a reduc-
tion in haem-associated stress may be an additional factor 
enabling the survival of SCVs during chronic infection.54 
Genes governing other aspects of general metabolic pathways 
associated with energy production and respiration in SCVs 
often also carry mutations (Table 1). hey primarily include 
genes encoding proteins of the Entner–Doudorof pathway, 
reconciling the slower growth rate of SCVs that contributes 
to their persistence.
Increased adhesion and bioilm formation are correlated 
with the enhanced expression of surface-bound adhesins and 
their cognate transcriptional regulators.55–58 Adhesins not only 
function as a means of binding directly to host proteins prior to 
colonization but also enable interbacterial aggregation, which 
is critical to the development of bioilm; SCVs are characteris-
tically proliic bioilm-forming organisms.59 he expression of 
adhesin genes is often governed by global transcriptional regu-
lators that form part of an intricate transcriptional network 
that responds to environmental cues, usually involving quo-
rum sensing. herefore, it is not surprising to ind that genes 
encoding transcriptional regulators, such as agr, sigB, and sarA, 
are diferentially regulated in SCVs of both Bacillus cereus and 
S. aureus (Table 1).60–65 Indeed, during chronic infection where 
the SCV phenotype begins to emerge, the expression of these 
transcriptional regulators is repressed, thus suppressing viru-
lence gene expression, promoting intracellular survival, and 
dampening the host immune response (Table 1).66
Although diferentially expressed or mutated genes tend 
to be conserved in SCVs, to date no deined core set of SCV 
genes has been documented. Often SCV-associated pheno-
typic traits are not the result of permanent genetic mutations 
but may instead result from genome rearrangements; there-
fore, identifying SCVs at the genotypic level is potentially as 
challenging as identifying them based on phenotype alone. 
Moreover, numerous phenotypic traits can be attributed to 
epigenetics.67 Where genetic traits are conserved, they usually 
confer essential adaptations; transient characteristics that are 
not an absolute requirement for survival, but which confer a 
competitive advantage, are likely controlled by uncharacter-
ized global transcriptional regulators or alternative sigma fac-
tors (Table 1) that form part of a larger and as yet undeined 
SCV regulon. Since only traits that are conferred by permanent 
genetic change are heritable, the maintenance of a stable SCV 
community within the larger microbial consortia is postulated 
to depend on appropriate regulatory signals. Signiicantly, 
DNA mismatch repair systems are often impaired in SCVs, 
leading to the accumulation of genetic mutations that confer 
the typical SCV phenotype or, in some cases, result in hyper-
mutability and alternative variant phenotypes.68
SCVs within Microbial Communities
Variants occur at random within microbial populations; most 
are transitory with only those changes that allow bacteria 
to remain viable and confer an advantage becoming ixed 
within a population. Microbial adaptation to a particular 
environment and competition between the members of a 
heterogeneous population, comprising a parent (wild type) 
and progeny (including mutants), are dictated by growth 
parameters and stresses.69 Numerous laboratory studies have 
demonstrated that successful microorganisms, namely, those 
that succeed within a given environment, do so because they 
exhibit the highest growth rate under prevailing conditions.70 
Despite this, SCVs persist within microbial communities, 
albeit as a minor constituent that is never entirely outcom-
peted by the parental strain. Given the tenacity of SCVs to 
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survive under stress, it might be expected that they should 
eventually predominate. Certainly with regard to antimicro-
bial interventions,71 this is the case, as the more susceptible 
parent strain is eradicated leaving behind a population of 
SCVs that can undergo reversion, which results in a recur-
rence of infection (Fig. 2).72 SCVs that arise during human 
infection appear better adapted for survival and persistence 
within the host73 despite their impaired rate of growth and 
increased host dependency. Selection because of loss or redun-
dancy of metabolic activity is not unusual and under certain 
growth conditions,74 such as the host environment, might 
confer a itness advantage, if not in terms of growth, in terms 
of survival.75 Many host-adapted and therefore invariably 
host-dependent pathogens undergo reductive evolution;76 
driven by the host habitat and their ability to utilize host 
metabolites, such organisms become slow growing and nutri-
tionally fastidious, often adopting an intracellular lifestyle.77 
his process is ordinarily mediated by the loss of large frag-
ments of genomic DNA. SCVs appear similar to host-adapted 
pathogens, and the loss of metabolic function renders them 
reliant on the host to meet their nutritional needs;78 indeed, 
many SCVs survive intracellularly. Where reductive evolu-
tion occurs in pathogens, it is correlated with increased viru-
lence79 that is not observed for SCVs, which conversely seem 
to exhibit attenuated virulence.80 Signiicantly, pathogens 
that undergo reductive evolution do not regain “lost” genetic 
function81 unlike SCVs that are able to revert to WT or WT 
like once selective pressures, such as antimicrobial treatment, 
are removed (Figs. 1 and 2). herefore, for SCVs, there is 
apparently a trade-of between virulence and persistence that 
exploits the ability to revert to a WT or WT-like variant, 
which is less host dependent and regains virulence. he spe-
ciic adaptations that the minority SCV population depends 
on to ensure survival among their faster growing counterparts 
include the increased expression of surface adhesins as pre-
viously described. If two microorganisms are competing for 
the same human receptor, then those with a binding advan-
tage (ie, more surface adhesins) are more likely to adhere.82,83 
Combined with enhanced bioilm formation, such colonizers 
are less likely to be removed from the host by detachment.84 
Intracellular survival provides more than simple protection 
from immunity, with the cell cytoplasm providing a nutrition-
ally rich habitat for auxotrophic SCVs that is not aforded to 
the parental strain, but at the same time reduces competition 
for space at the tissue surface.85 It is proposed that in this way, 
both SCV and progenitor can coexist.
SCVs in Chronic Infection
SCVs show enhanced resistance to a range of antibiotics7,25,86–88 
and have been directly associated with persistent infections 
in a number of diseases, including, but not limited to, cys-
tic ibrosis,89,90 chronic obstructive pulmonary disease,91 
diabetic foot ulcers,92 chronic rhinosinusitis,93 chronic wound 
infections,94–96 systemic infections,97 and infections arising 
from surgical intervention or medical devices,98–102 which 
can lead to serious and sometimes fatal clinical consequences, 
such as endocarditis, bacteremia, or meningitis.97,102 It has 
been proposed that in the case of the ventriculoperitoneal 
shunt (a medical device used in the treatment of hydrocepha-
lus), SCV-associated meningitis infection can arise from 
inadequate disinfection of the shunt and failure to identify 
and treat these persistent variants.103 Chronic infections rep-
resent a signiicant burden to both patients and health-care 
providers. Where chronicity ensues, bioilm is frequently 
present.104–108 he presence of SCVs within bioilms has 
been directly linked to chronic antibiotic-resistant infec-
tions, including cystic ibrosis in lung, osteomyelitis, cath-
eter and pacemaker infection, among others as previously 
described.87–93,108–115 he respiratory tract of cystic ibrosis 
patients provides a unique environment for the selection of 
a subgroup of autoaggregative and highly adherent SCVs of 
Pseudomonas aeruginosa.20,115,116 hese SCVs are hyperpiliated 
and exhibit increased twitching motility as well as have the 
capacity to emerge and successfully endure in bioilms, thus 
contributing signiicantly to the pathogenesis of P. aeruginosa 
lung infection.115,116 However, it is the hyperaggregative 
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Figure 2. Pure populations of bacteria often comprise WT (major population; blue) and SCV (minor population; orange), which arise spontaneously; 
under environmental stress, such as antibiotic treatment, the WT population is diminished and SCVs survive; under sustained stress, such as a course 
of antibiotics to treat an infection, the SCVs become the dominant members of the population. When the selective pressure is removed, WT organisms 
SUROLIHUDWHDQGEHFRPHWKHGRPLQDQWPHPEHUVRIWKHSRSXODWLRQFRPSDUHGWRVORZJURZLQJ6&9V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WT phenotype or a WT-like phenotype (green), which regains characteristics that enable faster growth.
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property of these SCVs that is the primary contributing factor 
to etiology of chronic infection because it enables microorgan-
isms to produce large amounts of polysaccharide intercellular 
adhesion and highly structured bioilms.117 Signiicantly, 
a recent study describing polymicrobial bioilm comprising 
P. aeruginosa and S. aureus suggests that the cohabitation of 
these microorganisms not only leads to a more dense and 
stable bioilm formation but also induces SCV emergence, 
even in the absence of antibiotics.83 Speciically, SCV of 
S. aureus emerged following the exposure to 4-hydroxy-
2-heptylquinoline-N-oxide, secreted by P. aeruginosa, which 
is known to impair the growth of S. aureus. Growth impair-
ment was attributed to a shift to the slower growing SCV 
morphotype.118 his phenomenon has been best studied in 
cocultured organisms derived from patients with cystic ibro-
sis who present with chronic infection for which antibiotic 
treatment is received, where SCVs of S. aureus were identiied 
in 24% of the patients.119 It is believed that for S. aureus, this 
is a speciic survival strategy in the presence of P. aeruginosa, 
mediating protection from secreted exotoxin A, which targets 
the electron transport chain.25
he rate of occurrence of SCVs in chronic infection is 
likely to vary depending on the clinical conditions;7 nonethe-
less, SCVs are detected in approximately 1% of isolates in a 
clinical microbiology laboratory and their incidence is the 
highest in cystic ibrosis and osteomyelitis.7 It is pertinent to 
highlight that in patients with osteomyelitis, surgical place-
ment of slow-release gentamicin beads along with debride-
ment is a common practice for treatment and may be linked to 
SCV induction.120 his is of concern as inadvertent iatrogenic-
induced SCVs may be formed as a result of the long-term 
exposure to gentamicin; studies have veriied that SCVs can be 
recovered from patients undergoing treatment with gentami-
cin beads.120 It has consequently been suggested that routine 
screening for SCVs should take place for patients treated with 
gentamicin beads for osteomyelitis.28 Furthermore, given the 
recalcitrance of SCV-associated infection, it might seem rea-
sonable to screen persons who are predisposed to developing 
chronic infection following the completion of antimicrobial 
chemotherapy. herefore, with regard to eicacious antimi-
crobial treatments, the identiication of SCVs is as important 
as ensuring an appropriate dose of antimicrobial is adminis-
tered. However, this approach is confounded by the relatively 
limited information describing successful treatment of SCV 
infections. Since aminoglycosides are known to promote the 
emergence of SCVs in some bacterial species, including P. 
aeruginosa, they are unlikely to constitute a suitable treatment 
where such SCVs persist. Vancomycin exhibits a higher degree 
of eicacy against SCVs than most antibiotics, but its potency 
is estimated to be approximately half of that typically observed 
for the treatment of non-SCV organisms.121 It is possible to 
achieve bactericidal activity against S. aureus hemB mutants 
using daptomycin, and the efect is concentration dependent, 
suggesting that at its simplest, SCVs can be efectively treated 
using higher doses of antibiotics that are normally prescribed 
to treat infection.122 However, until satisfactory laboratory 
isolation is achieved, SCVs will remain very diicult to detect 
in patient samples and will, therefore, remain excluded from 
the standard antimicrobial testing regimens.
Future Perspectives
Although SCVs have been known to exist for over century, 
little attention was originally given to them as they were 
believed to be nonvirulent and therefore not clinically impor-
tant. However, as more is understood about their role in per-
sistent infections, it has become imperative that mechanisms 
of SCV persistence and resistance, as well as population 
dynamics, are thoroughly explored. Recent investigations 
have proposed a low-cost point-of-care test for the diagno-
sis of P. aeruginosa in patients at risk of chronic respiratory 
infection for rapid and economical diagnosis. his method, 
named electrochemical impedance spectroscopy, has suc-
cessfully diferentiated strains of P. aeruginosa based on their 
impedance signature, which is inluenced by factors such as 
pyocyanin secretion.123 While this method has not yet been 
tested using the SCVs of P. aeruginosa, many SCVs exhibit 
diferential pyocyanin production and so could be potentially 
identiied via this means that could replace traditional culture 
methods. With this in mind, it seems reasonable to suggest 
that accurate diagnosis of SCV-associated infections will rely 
on nontraditional diagnostics, including the use of molecular 
probes, in future. he principle complication for the develop-
ment of such diagnostic methodology is the varied phenotypic 
and genotypic traits exhibited by SCVs; without a core set 
of SCV genes even with new diagnostic techniques, it might 
prove as easy to misdiagnose SCVs in infection as by tradi-
tional culture.
Author Contributions
Conceived the concepts: BEJ, KJP, NPT, SEM. Analyzed 
the data: BEJ, KJP, NPT, SEM. Wrote the irst draft of the 
manuscript: BEJ, KJP, NPT, SEM. Contributed to the writ-
ing of the manuscript: BEJ, KJP, NPT, SEM. Agree with 
manuscript results and conclusions: BEJ, KJP, NPT, SEM. 
Jointly developed the structure and arguments for the paper: 
BEJ, KJP, NPT, SEM. Made critical revisions and approved 
inal version: BEJ, KJP, NPT, SEM. All authors reviewed and 
approved of the inal manuscript.
REFERENCES
 1. Kolle W, Hetsch H. Die experimentelle Bakteriologie und die Infektionskrankheiten 
mit besonderer Berücksichtigung der Immunitätslehre. Berlin, Germany: Urban und 
Schwarzenberg; 1913.
 2. Swingle EL. Studies on small colony variants of Staphylococcus aureus. J Bacteriol. 
1935;29(5):467–489.
 3. Hadley P, Delves E, Klimek J. he ilterable forms of bacteria: 1. A ilterable stage 
in the life history of the Shiga dysentery bacillus. J Infect Dis. 1931;48(1):1–159.
 4. Hale JH. Studies on Staphylococcus mutation: characteristics of the “G” 
(Gonidial) variant and factors concerned in its production. Br J Exp Pathol. 1947; 
28(3):202–210.
Small colony variants and their role in chronic infection 
21MICROBIOLOGY INSIGHTS 2015:8
 5. Gerber AU, Craig WA. Aminoglycoside-selected subpopulations of Pseudomonas 
aeruginosa: characterisation and virulence in normal and leukopenic mice. J Lab 
Clin Med. 1982;100:671–681.
 6. Musher DM, Baughn RE, Merrell GL. Selection of small-colony variants of 
Enterobacteriaceae by in vitro exposure to aminoglycosides: pathogenicity for 
experimental animals. J Infect Dis. 1979;140:209–214.
 7. Proctor RA, von Eif C, Kahl BC, et al. Small colony variants: a pathogenic form 
of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol. 
2006;4(4):295–305.
 8. McNamara PJ, Proctor RA. Staphylococcus aureus small colony variants, electron 
transport and persistent infections. Int J Antimicrob Agents. 2000;14(2):117–122.
 9. Wilson SG, Sanders CC. Selection and characterisation of strains of Staphylococ-
cus aureus displaying unusual resistance to aminoglycosides. Antimicrob Agents 
Chemother. 1976;10(3):519–525.
 10. Proctor RA, Kahl B, von Eif C, Vaudaux PE, Lew DP, Peters G. Staphylococcus 
small colony variants have novel mechanisms for antibiotic resistance. Clin Infect 
Dis. 1998;27(suppl 1):S68–S74.
 11. Allegrucci M, Sauer K. Formation of Streptococcus pneumoniae non-phase-
variable colony variants is due to increased mutation frequency present under 
bioilm growth conditions. J Bacteriol. 2008;190(19):6330–6339.
 12. von Eif C. Staphylococcus aureus small colony variants: a challenge to microbiolo-
gists and clinicians. Int J Antimicrob Agents. 2008;31(6):507–510.
 13. Onyango LA, Dunstan RH, Roberts TK, Macdonald MM, Gottfries J. Phe-
notypic variants of Staphylococci and their underlying population distributions 
following exposure to stress. PLoS One. 2013;8(10):e77614.
 14. Massey RC, Buckling A, Peacock SJ. Phenotypic switching of antibiotic resistance cir-
cumvents permanent costs in Staphylococcus aureus. Curr Biol. 2001;11(22):1810–1814.
 15. Chatterjee I, Herrmann M, Proctor RA, Peters G, Kahl BC. Enhanced post-
stationary-phase survival of a clinical thymidine-dependent small-colony variant 
of Staphylococcus aureus results from lack of a functional tricarboxylic acid cycle. 
 J Bacteriol. 2007;189(7):2936–2940.
 16. Besier S, Zander J, Kahl BC, Kraiczy P, Brade V, Wichelhaus TA. he 
thymidine-dependent small-colony-variant phenotype is associated with hyper-
mutability and antibiotic resistance in clinical Staphylococcus aureus isolates. Anti-
microb Agents Chemother. 2008;52(6):2183–2189.
 17. Besier S, Ludwig A, Ohlsen K, Brade V, Wichelhaus TA. Molecular analysis 
of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus 
aureus. Int J Med Microbiol. 2007;297(4):217–225.
 18. Kaplan ML, Dye W. Growth requirements of some small-colony-forming vari-
ants of Staphylococcus aureus. J Clin Microbiol. 1976;4(4):343–348.
 19. Pan XS, Hamlyn PJ, Talens-Visconti R, Alovero FL, Manzo RH, Fisher LM.Small-
colony mutants of Staphylococcus aureus allow selection mediated resistance to dual-
target luoroquinolones. Antimicrob Agents Chemother. 2002;46(8):2498–2506.
 20. Häussler S, Rohde M, Steinmetz I. Highly resistant Burkholderia pseudomallei 
small colony variants isolated in vitro and in experimental mellioidosis. Med 
Microbiol Immunol. 1999;188(2):91–97.
 21. Häussler S, Ziegler I, Löttel A, et al. Highly adherent small-colony variants of Pseu-
domonas aeruginosa in cystic ibrosis lung infection. J Med Microbiol. 2003;52(4): 
295–301.
 22. Seaman PF, Ochs D, Day MJ. Small-colony variants: a novel mechanism for triclo-
san resistance in methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 
2007;59(1):43–50.
 23. Bayston R, Ashraf W, Smith T. Triclosan resistance in methicillin-resistant 
Staphylococcus aureus expressed as small colony variants: a novel mode of evasion 
of susceptibility to antiseptics. J Antimicrob Chemother. 2007;59:848–853.
 24. Lenhard JR, von Eif C, Hong IS, et al. Evolution of Staphylococcus aureus under 
vancomycin selective pressure: the role of the small-colony variant phenotype. 
Antimicrob Agents Chemother. 2015;59(2):1347–1351.
 25. Hofman LR, Déziel E, D’Argenio DA, et al. Selection for Staphylococcus aureus 
small-colony variants due to growth in the presence of Pseudomonas aeruginosa. 
Proc Natl Acad Sci U S A. 2006;103(52):19890–19895.
 26. Crompton MJ, Dunstan RH, Macdonald MM, Gottfries J, von Eif C, Roberts TK. 
Small changes in environmental parameters lead to alterations in antibiotic resis-
tance, cell morphology and membrane fatty acid composition in Staphylococcus 
lugdunensis. PLoS One. 2014;9(4):e92296.
 27. Lannergård J, von Eif C, Sander G, et al. Identiication of the genetic basis for 
clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus 
aureus. Antimicrob Agents Chemother. 2008;52:4017–4022.
 28. Dean MA, Olsen RJ, Long SW, Rosato AE, Mausser JM. Identiication of point 
mutations in clinical Staphylococcus aureus strains that produce small colony vari-
ants auxotrophic for menadione. Infect Immun. 2014;82:1600–1605.
 29. Bentley R, Meganathan R. Biosynthesis of vitamin K (menaquinone) in bacteria. 
Microbiol Rev. 1982;46:241–280.
 30. Kahl BC, Belling G, Reichelt R, Herrmann M, Proctor RA, Peters G. 
hymidine-dependent small-colony variants of Staphylococcus aureus exhibit gross 
morphological and ultrastructural changes consistent with impaired cell separa-
tion. J Clin Microbiol. 2003;41(1):410–413.
 31. Baumert N, von Eif C, Schaaf F, Peters G, Proctor RA, Sahl HG. Physiology 
and antibiotic susceptibility of Staphylococcus aureus small colony variants. Microb 
Drug Resist. 2002;8:253–260.
 32. Mayield JA, Hammer ND, Kurker RC, et al. he chlorite dismutase (HemQ ) 
from Staphylococcus aureus has a redox-sensitive heme and is associated with the 
small colony variant phenotype. J Biol Chem. 2013;288(32):23488–23504.
 33. Wellingausen N, Chatterjee I, Berger A, Niederfuehr A, Proctor RA, Kahl BC. 
Characterization of clinical Enterococcus faecalis small-colony variants. J Clin 
Microbiol. 2009;47(9):2802–2811.
 34. Aoki Y, Yamauchi Y, Hayashi H, Takayama Y, Tsuji A. Characterization of 
small colony variants of methicillin-resistant Staphylococcus aureus regrown in the 
presence of arbekacin. J Infect Chemother. 1998;4(3):107–111.
 35. Adler H, Schraner EM, Frei R, Wild P. Ultrastructure of a clinical isolate of Staph-
ylococcus aureus small colony variant and its revertant. Microsc Microanal. 2005; 
11(2):982–983.
 36. Vaudaux P, Francois P, Bisognano C, et al. Increased expression of clump-
ing factor and ibronectin-binding proteins by hemB mutants of Staphylococcus 
aureus expressing small colony variant phenotypes. Infect Immun. 2002;70(10): 
5428–5437.
 37. Kohler C, von Eif C, Peters G, Proctor RA, Hecker M, Engelmann S. Physi-
ological characterisation of a heme-deicient mutant of Staphylococcus aureus by 
proteomic approach. J Bacteriol. 2003;185(33):6926–6937.
 38. Kahl BC, Belling G, Becker P, et al. hymidine-dependent Staphylococcus aureus 
small-colony variants are associated with extensive alterations in regulator and 
virulence gene expression proiles. Infect Immun. 2005;73(7):4119–4126.
 39. Clements MO, Watson SP, Poole RK, Foster SJ. CtaA of Staphylococcus aureus is 
required for starvation survival, recovery, and cytochrome biosynthesis. J Bacteriol. 
1999;181(2):501–507.
 40. Atalla H, Gyles C, Mallard B. Staphylococcus aureus small colony variants (SCVs) 
are their role in disease. Anim Health Res Rev. 2011;12(1):33–45.
 41. Sendi P, Proctor RA. Staphylococcus aureus as an intracellular pathogen: the role 
of small colony variants. Trends Microbiol. 2009;17(2):54–58.
 42. Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, et al. Regulation of cell 
adhesion and anchorage-dependent growth by a new beta 1-integrin-linked pro-
tein kinase. Nature. 1996;379(6560):91–96.
 43. Kalinka J, Hachmeister M, Geraci J, et al. Staphylococcus aureus isolates from 
chronic osteomyelitis are characterized by high host cell invasion and intracel-
lular adaption, but still induce inlammation. Int J Med Microbiol. 2014;304(8): 
1038–1049.
 44. Balwit JM, van Langevelde P, Vann JM, Proctor RA. Gentamicin-resistant 
menadione and hemin auxotrophic Staphylococcus aureus persist within cultured 
endothelial cells. J Infect Dis. 1994;170:1033–1037.
 45. von Eif C, Heilmann C, Proctor RA, Woltz C, Peters G, Gotz F. A site directed 
Staphylococcus aureus hemB mutant is a small colony variant which persists intra-
cellularly. J Bacteriol. 1997;179:4706–4712.
 46. von Eif C, Becker K, Metze D, et al. Intracellular persistence of Staphylococcus aureus 
small-colony variants within keratinocytes: a cause for antibiotic treatment failure in 
patients with Darier’s disease. Clin Infect Dis. 2001;32(11):1643–1647.
 47. Kahl B, Herrmann M, Everding AS, et al. Persistent infection with small colony 
variant strains of Staphylococcus aureus in patients with cystic ibrosis. J Infect Dis. 
1998;177(4):1023–1029.
 48. Schröder A, Kland R, Peschel A, von Eif C, Aepfelbacher M. Live cell imaging of 
phagosome maturation in Staphylococcus aureus infected human endothelial cells: 
small colony variants are able to survive in lysosomes. Med Microbiol Immunol. 
2006;195(4):185–194.
 49. Proctor RA, van Langevelde P, Kristjansson M, Maslow JN, Arbeit RD. Persis-
tent and relapsing infections associated with small-colony variants of Staphylococ-
cus aureus. Clin Infect Dis. 1995;20(1):95–102.
 50. Kipp F, Ziebuhr W, Becker K, et al. Detection of Staphylococcus aureus by 16s 
rRNA directed in situ hybridisation in a patient with a brain abscess caused by 
small colony variants. J Clin Pathol. 2003;56(10):746.
 51. Seggewiss J, Becker K, Kotte O, et al. Reporter metabolite analysis of transcrip-
tional proiles of a Staphylococcus aureus strain with normal phenotype and its iso-
genic hemB mutant displaying the small-colony-variant phenotype. J Bacteriol. 
2006;188:7765–7777.
 52. Bates DM, von Eiff C, McNamara PJ, et al. Staphylococcus aureus mend 
and hemB mutants are as infective as the parent strains, but the menadione 
biosynthetic mutant persists within the kidney. J Infect Dis. 2003;187(10): 
1654–1661.
 53. Wakeman CA, Hammer ND, Stauf DL, et al. Menaquinone biosynthesis 
potentiates haem toxicity in Staphylococcus aureus. Mol Microbiol. 2012;86(6): 
1376–1392.
 54. Granick S, Beale SI. Hemes, chlorophylls, and related compounds: biosynthesis 
and metabolic regulation. Adv Enzymol Relat Areas Mol Biol. 1978;46:33–203.
 55. Ythier M, Resch G, Waridel P, et al. Proteomic and transcriptomic proiling of 
Staphylococcus aureus surface LPXTG-proteins: correlation with agr genotypes 
and adherence phenotypes. Mol Cell Proteomics. 2012;11:1123–1139.
Johns et al
22 MICROBIOLOGY INSIGHTS 2015:8
 56. Cerca N, Brooks JL, Jeferson KK. Regulation of the intercellular adhesin locus 
regulator (icaR) by SarA, sigma B, and IcaR in Staphylococcus aureus. J Bacteriol. 
2008;190(19):6530–6533.
 57. Da Re S, Le Quéré B, Ghigo JM, Beloin C. Tight modulation of Escherichia coli 
bacterial bioilm formation through controlled expression of adhesion factors. 
Appl Environ Microbiol. 2007;73:3391–3403.
 58. Prigent-Combaret C, Brombacher E, Vidal O, et al. Complex regulatory net-
work controls initial adhesion and bioilm formation in Escherichia coli via regu-
lation of the csgD gene. J Bacteriol. 2001;183:7213–7223.
 59. von Eif C, McNamara P, Becker K, et al. Phenotype microarray proiling of 
Staphylococcus aureus menD and hemB mutants with the small-colony-variant 
phenotype. J Bacteriol. 2006;188(2):687–693.
 60. Möbius K, Arias-Cartin R, Breckau D, et al. Heme biosynthesis is coupled to elec-
tron transport chains for energy generation. Proc Natl Acad Sci U S A. 2010;107(23): 
10436–10441.
 61. Sinha B, François PP, Nüsse O, et al. Fibronectin-binding protein acts as Staphy-
lococcus aureus invasion via ibronectin bridging to integrin to alpha5beta1. Cell 
Microbiol. 1999;1(2):101–117.
 62. Mitchell G, Fugère A, Pépin Gaudreau K, et al. SigB is a dominant regulator 
of virulence in Staphylococcus aureus small-colony variants. PLoS One. 2013;8(5): 
e65018.
 63. Moisan H, Brouillette E, Jacob CL, Langlois-Bégin P, Michaud S, Malouin F. 
Transcription of virulence factors in Staphylococcus aureus small-colony variants 
isolated from cystic ibrosis patients is inluenced by SigB. J Bacteriol. 2006; 
188(1):64–78.
 64. Valle J, Toledo-Arana A, Berasain C, et al. SarA and not σB is essential for bio-
ilm development by Staphylococcus aureus. Mol Microbiol. 2003;48(4):1075–1087.
 65. Tuchscherr L, Bischof M, Lattar SM, et al. Sigma factor SigB is crucial to 
mediate Staphylococcus aureus adaption during chronic infections. PLoS Pathog. 
2015;11(4):e1004870.
 66. Tormo MA, Martí M, Valle J, et al. SarA is an essential positive regulator of Staph-
ylococcus epidermidis bioilm development. J Bacteriol. 2005;187(7):2348–2358.
 67. Casadesús J, Low D. Epigenetic gene regulation in the bacterial world. Microbiol 
Mol Biol Rev. 2006;70:3830–3885.
 68. van Schaik W, Zwietering MH, de Vos WM, Abee T. Deletion of the SigB gene 
in Bacillus cereus ATCC 14579 leads to hydrogen peroxide hyper resistance. Appl 
Environ Microbiol. 2005;71(10):6427–6430.
 69. Galhardo RS, Hastings PJ, Rosenberg SM. Mutation as a stress response and the 
regulation of evolvability. Crit Rev Biochem Mol Biol. 2007;42:399–435.
 70. Michelsen CF, Christensen AM, Bojer MS, Hoiby N, Ingmer H, Jelsbak L. 
Staphylococcus aureus alters growth activity, autolysis, and antibiotic tolerance 
in a human adapted Pseudomonas aeruginosa lineage. J Bacteriol. 2014;196: 
3903–3911.
 71. Brouillette E, Martinez A, Boyll BJ, Allen NE, Malouin F. Persistence of Staph-
ylococcus aureus small colony variant under antibiotic pressure in vivo. FEMS 
Immunol Med Microbiol. 2004;41:35–41.
 72. Smania AM, Segura I, Pezza RJ, Becerra C, Albesa I, Argarana CE. Emergence 
of phenotypic variants upon mismatch repair disruption in Pseudomonas aerugi-
nosa. Microbiology. 2004;150:1327–1338.
 73. Mitchell G, Grundin G, Bilodeau G, Cantrin AM, Malouin F. Infection of 
polarized airway epithelial cells by normal and small colony variant strains of 
Staphylococcus aureus is increased in cells with abnormal cystic ibrosis transmem-
brane conductive regulator function and is inluenced by NF-KB. Infect Immun. 
2011;79:3541–3551.
 74. Blivn KA, Mavrelli AT. Antivirulence genes: insights into pathogen evolution 
through gene loss. Infect Immun. 2012;80:4016–4070.
 75. Orr HA. he genetic theory of adaptation: a brief history. Nat Rev Genet. 2005;6: 
119–127.
 76. Song H, Hwang J, Yi H, et al. he early stage of bacterial genome-reductive 
evolution in the host. PLoS Pathog. 2010;6:e1000922.
 77. Alder H, Widmer A, Frei R. Emergence of teicoplanin-resistant small colony 
variant of Staphylococcus epidermidis during vancomycin therapy. Eur J Clin 
Microbiol Infect Dis. 2003;22:746–748.
 78. Kriegeskorte A, Grubmüller S, Huber C, et al. Staphylococcus aureus small colony 
variants show common metabolic features in central metabolism irrespective of 
underlying auxotrophism. Front Cell Infect Microbiol. 2014;4:141.
 79. Cole J. Nitrate reduction to ammonia by enteric bacteria: redundancy or a strat-
egy for survival during oxygen starvation? FEMS Lett Microbiol. 1996;136: 
1–11.
 80. Toft C, Andersson SG. Evolutionary microbial genomics: insights into bacterial 
host adaptation. Nat Rev Genet. 2010;11:465–475.
 81. Dagan T, Blekhman R, Graur D. he “domino theory” of gene death: gradual 
and mass gene extinction events in the lineages of obligate symbiotic bacterial 
pathogens. Mol Biol Evol. 2006;23(2):310–316.
 82. Merhej V, Geogiades K, Raoult D. Postgenomic analysis of bacterial pathogens 
repertoire reveals genome reduction rather than virulence factors. Brief Funct 
Genomics. 2013;12:291–304.
 83. Kumar A, Ting YP. Presence of Pseudomonas aeruginosa inluences bioilm for-
mation and surface protein expression of Staphylococcus aureus. Environ Microbiol. 
2015. Epub ahead of print. doi:10.1111/1462-2920.12890.
 84. Gopal PK, Prasad J, Smart J, Gill HS. In vitro adherence properties of Lac-
tobacillus rhamnosus DR20 and Biidobacterium lactis DR10 strains and their 
antagonistic activity against an enterotoxigenic Escherichia coli. Int J Food Micro-
biol. 2001;67:207–216.
 85. Bibel DJ, Aly R, Bayles C, Straus WG, Shineield HR, Maibach HI. Com-
petitive adherence as a mechanism for bacterial interference. Can J Microbiol. 
1983;29:700–703.
 86. Sifri CD, Baresh-Bernal A, Calderwood SB, von Eif C. Virulence of Staphylo-
coccus aureus small colony variants in the Caenorhabditis elegans infection model. 
Infect Immun. 2006;74(2):1091–1096.
 87. Miller MH, Wexler MA, Steigbigel NH. Single and combination antibi-
otic therapy of Staphylococcus aureus experimental endocarditis: emergence of 
gentamicin-resistant mutants. Antimicrob Agents Chemother. 1978;14(3):336–343.
 88. Delgado-Valverde M, Fernández-Echauri P, Batista-Diaz N, Pascual-Hernández 
A. Small-colony variants of Staphylococcus aureus: usefulness of various test [sic] for 
diagnosis and susceptibility study. Enferm Infecc Microbiol Clin. 2014;32(2):96–98.
 89. Sadowska B, Bonar A, von Eif C, et al. Characteristics of Staphylococcus aureus, 
isolated from airways of cystic ibrosis patients, and their small colony variants. 
FEMS Immunol Med Microbiol. 2002;32(3):191–197.
 90. Evans TJ. Small colony variants of Pseudomonas aeruginosa in chronic bacterial 
infection of the lung in cystic ibrosis. Future Microbiol. 2015;10(2):231–239.
 91. Cullen L, McClean S. Bacterial adaption during chronic respiratory infections. 
Pathogens. 2015;4(1):66–89.
 92. Cervantes-García E, García-Gonzalez R, Reyes-Torres A, Resendiz-Albor AA, 
Salazar-Schettino PM. Staphylococcus aureus small colony variants in diabetic 
foot infections. Diabet Foot Ankle. 2015;6:26431.
 93. Tan NC, Cooksley CM, Roscioli E, et al. Small-colony variants and phenotype 
switching of intracellular Staphylococcus aureus in chronic rhinosinusitis. Allergy. 
2014;69:1364–1371.
 94. Abele-Horn M, Schupfner B, Emmerling P, Waldner H, Göring H. Persis-
tent wound infection after herniotomy associated with small-colony variants of 
Staphylococcus aureus. Infection. 2000;28(1):53–54.
 95. Posnett J, Franks PJ. he burden of chronic wounds in the UK. Nurs Times. 
2008;104(3):44–45.
 96. Siddiqui AR, Bernstein JM. Chronic wound infection: facts and controversies. 
Clin Dermatol. 2010;28(5):519–526.
 97. Agarwal H, Verrall R, Singh SP, Tang YW, Wilson G. Small colony variant Staph-
ylococcus aureus multiorgan infection. Pediatr Infect Dis J. 2007;26(3):269–271.
 98. Tande AJ, Osmon DR, Greenwood-Quaintance KE, Mabry TM, Hanssen AD, 
Patel R. Clinical characteristics and outcomes of prosthetic joint infection caused 
by small colony variant staphylococci. MBio. 2014;5(5):e1910–e1914.
 99. Roggenkamp A, Sing A, Hornef M, Brunner U, Autenrieth IB, Heesemann J. 
Chronic prosthetic hip infection caused by a small-colony variant of Escherichia 
coli. J Clin Microbiol. 1998;36(9):2530–2534.
 100. Pifaut C, Lustig S, Laurent F, Chidiac C, Ferry T. Small colony variant-producing 
S aureus prosthesis joint infection highlighted by sonication and treated with 
prolonged high doses of daptomycin. BMJ Case Rep. 2013;2013. doi:10.1136/
bcr-2013-008637.
 101. Idelevich EA, Pogoda CA, Ballhausen B, et al. Pacemaker lead infection and 
related bacteraemia caused by normal and small colony variant phenotypes of 
Bacillus licheniformis. J Med Microbiol. 2013;62(6):940–944.
 102. Maduka-Ezeh A, Seville MT, Kusne S, et al. hymidine auxotrophic Staphylo-
coccus aureus small-colony variant endocarditis and left ventricular assist device 
infection. J Clin Microbiol. 2012;50(3):1102–1105.
 103. Spanu T, Romano L, D’Inzeo T, et al. Recurrent ventriculoperitoneal shunt infection 
caused by small-colony variants of Staphylococcus aureus. Clin Infect Dis. 2005;41(5): 
e48–e52.
 104. Maduka-Ezeh AN, Greenwood-Quaintance KE, Karau MJ, et al. Antimi-
crobial susceptibility and bioilm formation of Staphylococcus epidermidis small 
colony variants associated with prosthetic join infection. Diagn Microbiol Infect 
Dis. 2012;74(3):224–229.
 105. Pradeep Kumar SS, Easwer HV, Maya Nandkumar A. Multiple drug resistant 
bacterial bioilms on implanted catheters—a reservoir of infection. J Assoc Physi-
cians India. 2013;61(10):702–707.
 106. Bjarnsholt T. he role of bacterial bioilms in chronic infections. APMIS Suppl. 
2013;136:1–51.
 107. Flemming HC, Wingender J. he bioilm matrix. Nat Rev Microbiol. 2010;8(9): 
623–633.
 108. Bui LM, Turnidge JD, Kidd SP. he induction of Staphylococcus aureus bioilm 
formation of small colony variants is a strain-speciic response to host-generated 
chemical stresses. Microbes Infect. 2015;17(1):77–82.
 109. Jeukens J, Boyle B, Kukavica-Ibrulj I, et al. Comparative genomics of isolates of 
a Pseudomonas aeruginosa epidemic strain associated with chronic lung infections 
of cystic ibrosis patients. PLoS One. 2014;9(2):e87611.
Small colony variants and their role in chronic infection 
23MICROBIOLOGY INSIGHTS 2015:8
 110. Rit K. A case report of small colony variant of Staphylococcus aureus isolated from 
a patient with chronic osteomyelitis [sic] in a tertiary care hospital of eastern 
India. Adv Biomed Res. 2014;3:32.
 111. Häussler S, Tümmler B, Weissbrodt H, Rohde M, Steinmetz I. Small-colony 
variants of Pseudomonas aeruginosa in cystic ibrosis. Clin Infect Dis. 1999;29(3): 
621–625.
 112. von Eif C, Vaudaux P, Kahl BC, et al. Bloodstream infections caused by 
small-colony variants of coagulase-negative staphylococci following pacemaker 
implantation. Clin Infect Dis. 1999;29(4):932–934.
 113. Sendi P, Rohrbach M, Graber P, Frei R, Ochsner PE, Zimmerli W. Staphylo-
coccus aureus small colony variants in prosthetic joint infection. Clin Infect Dis. 
2006;43(8):961–967.
 114. Singh R, Ray P, Das A, Sharma M. Enhanced production of exopolysaccha-
ride matrix and bioilm by a menadione-auxotrophic Staphylococcus aureus small-
colony variant. J Med Microbiol. 2010;59(5):521–527.
 115. von Götz F, Häussler S, Jordan D, et al. Expression analysis of a highly adherent 
and cytotoxic small colony variant of Pseudomonas aeruginosa isolated from a lung 
of a patient with cystic ibrosis. J Bacteriol. 2004;186(12):3837–3847.
 116. Ikeno T, Fukuda K, Ogawa M, Honda M, Tanabe T, Taniguchi H. Small and 
rough colony Pseudomonas aeruginosa with elevated bioilm formation ability iso-
lated in hospitalized patients. Microbiol Immunol. 2007;51(10):929–938.
 117. Al Laham N, Rohde H, Sander G, et al. Augmented expression of polysac-
charide intercellular adhesin in a deined Staphylococcus epidermidis mutant with 
small-colony-variant phenotype. J Bacteriol. 2007;189(12):4494–4501.
 118. Mitchell G, Séguin DL, Asselin AE, et al. Staphylococcus aureus sigma B depen-
dent emergence of small colony variants and bioilm production following expo-
sure to Pseudomonas aeruginosa 4-hydroxy-2-hepylquinoline-N-oxide. BMC 
Microbiol. 2010;10:33.
 119. Schneider M, Muhlemann K, Droz S, Courzinet S, Casualta C, Zimmerli S. 
Clinical characteristics associated with isolation of small colony variants of 
Staphylococcus aureus and Pseudomonas aeruginosa from respiratory secretions of 
patients with cystic ibrosis. J Clin Microbiol. 2008;46:1832–1834.
 120. von Eif C, Bettin D, Proctor RA, et al. Recovery of small colony variants of 
Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin 
Infect Dis. 1997;25(5):1250–1251.
 121. Tsuji BT, von Eif C, Kelchlin PA, Forrest A, Smith PF. Attenuated vancomy-
cin bactericidal activity against Staphylococcus aureus hemB mutants expressing 
the small-colony-variant phenotype. Antimicrob Agents Chemother. 2008;52(4): 
1533–1537.
 122. Begic D, von Eif C, Tsuji BT. Daptomycin pharmacodynamics against Staph-
ylococcus aureus hemB mutants displaying the small colony variant phenotype. 
J Antimicrob Chemother. 2009;63(5):977–981.
 123. Ward AC, Connolly P, Tucker NP. Pseudomonas aeruginosa can be detected in 
a polymicrobial competition model using impedance spectroscopy with a novel 
biosensor. PLoS One. 2014;9(3):e91732. 
